MediSieve Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
13
MediSieve General Information
Description
Operator of a biotechnology company intended to develop magnetic blood filtration devices for treating blood-borne diseases. The company offers a magnetic haemofiltration platform that enables the physical removal of specific substances from the bloodstream of patients and can be used as a direct treatment, or to increase the safety and efficacy of other therapies or physically remove specific substances from the bloodstream of patients, enabling hospitals and healthcare firms to tackle diseases such as sepsis, malaria, Covid-19 and remove human plasma.
Contact Information
Website
www.medisieve.comCorporate Office
- Scale Space White City
- 58 Wood Lane
- London W12 7RZ
- England, United Kingdom
Corporate Office
- Scale Space White City
- 58 Wood Lane
- London W12 7RZ
- England, United Kingdom
MediSieve Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 18. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 17. Accelerator/Incubator | 19-May-2022 | Completed | Clinical Trials - Phase 1 | |||
| 16. Later Stage VC | Completed | Clinical Trials - Phase 1 | ||||
| 15. Later Stage VC | Completed | Clinical Trials - Phase 1 | ||||
| 14. Later Stage VC (Series A) | 21-May-2021 | Completed | Clinical Trials - Phase 1 | |||
| 13. Grant | 01-Jan-2021 | Completed | Clinical Trials - Phase 1 | |||
| 12. Grant | 30-Nov-2020 | Completed | Clinical Trials - Phase 1 | |||
| 11. Grant | 14-Jul-2020 | Completed | Clinical Trials - Phase 1 | |||
| 10. Grant | 01-Feb-2019 | $3.3M | $3.43M | Completed | Clinical Trials - Phase 1 | |
| 9. Grant | 01-Sep-2018 | $742K | $3.43M | Completed | Clinical Trials - Phase 1 |
MediSieve Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 3,035 | $0.013979 | $16.12 | $16.12 | 1x | $16.12 | 0.83% | |
| Ordinary | 34,996 | $0.013979 | $13.98 | $13.98 | 1x | $13.98 | 9.59% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
MediSieve Comparisons
Industry
Financing
Details
MediSieve Competitors (7)
One of MediSieve’s 7 competitors is Hemotune, a Venture Capital-Backed company based in Zurich, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hemotune | Venture Capital-Backed | Zurich, Switzerland | ||||
| Enable Injections | Venture Capital-Backed | Cincinnati, OH | ||||
| Nemera | Private Equity-Backed | Lyon, France | ||||
| ExThera Medical | Venture Capital-Backed | Martinez, CA | ||||
| Cytosorbents | Corporation | Princeton, NJ |
MediSieve Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MediSieve Patents
MediSieve Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3490716-B1 | Magnetic capturing system and method | Active | 28-Jul-2016 | ||
| AU-2017304767-A1 | Magnetic mixer and method | Inactive | 28-Jul-2016 | ||
| CA-3031721-A1 | Magnetic mixer and method | Pending | 28-Jul-2016 | ||
| EP-3490716-A1 | Magnetic mixer and method | Active | 28-Jul-2016 | ||
| US-10639602-B2 | Magnetic mixer and method | Active | 28-Jul-2016 |
MediSieve Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MediSieve Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Change Makers | Accelerator/Incubator | |||
| UK Research and Innovation | Government | Minority | ||
| SBRI Healthcare | Government | |||
| 24Haymarket | Venture Capital | Minority | ||
| UCL Ventures | University | Minority |
MediSieve FAQs
-
When was MediSieve founded?
MediSieve was founded in 2014.
-
Where is MediSieve headquartered?
MediSieve is headquartered in London, United Kingdom.
-
What is the size of MediSieve?
MediSieve has 6 total employees.
-
What industry is MediSieve in?
MediSieve’s primary industry is Drug Delivery.
-
Is MediSieve a private or public company?
MediSieve is a Private company.
-
What is MediSieve’s current revenue?
The current revenue for MediSieve is .
-
How much funding has MediSieve raised over time?
MediSieve has raised $20.3M.
-
Who are MediSieve’s investors?
Change Makers, UK Research and Innovation, SBRI Healthcare, 24Haymarket, and UCL Ventures are 5 of 13 investors who have invested in MediSieve.
-
Who are MediSieve’s competitors?
Hemotune, Enable Injections, Nemera, ExThera Medical, and Cytosorbents are some of the 7 competitors of MediSieve.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
